Literature DB >> 17071812

Giant Sertoli cell nodule of the testis: distinction from other Sertoli cell lesions.

A Barghorn1, H-R Alioth, S Hailemariam, F Bannwart, T M Ulbright.   

Abstract

The case of a 33-year-old man with a clinically suspected testicular neoplasm is reported here. The radical orchidectomy specimen showed a sharply demarcated, firm, yellow-white 1-cm nodule beneath the tunica albuginea at the upper pole. Microscopical examination showed the encapsulated nodule to be composed of tubules lined by immature Sertoli cells with interspersed spermatogonia and an interwoven network of hyalinised basement membrane having foci of calcification. Immunohistochemical studies verified the fetal phenotype of the Sertoli cells and the non-neoplastic nature of the germ cell component. Except for the large size, the findings were identical to those of a Sertoli cell nodule-a typically microscopic, unencapsulated lesion commonly detected in cryptorchid testes. The term "giant Sertoli cell nodule" is used for this unique, hitherto undescribed lesion and its distinction from other Sertoli cell lesions of the testis is considered here.

Entities:  

Mesh:

Year:  2006        PMID: 17071812      PMCID: PMC1860496          DOI: 10.1136/jcp.2005.035253

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  10 in total

1.  The androgen insensitivity syndrome (testicular feminization): a clinicopathologic study of 43 cases.

Authors:  J L Rutgers; R E Scully
Journal:  Int J Gynecol Pathol       Date:  1991       Impact factor: 2.762

2.  Hyperplasia and neoplasia of the Sertoli cell.

Authors:  A L STALKER; W T HENDRY
Journal:  J Pathol Bacteriol       Date:  1952-01

3.  Differentiation markers of Sertoli cells and germ cells in fetal and early postnatal human testis.

Authors:  Folker E Franke; Katharina Pauls; Rodolfo Rey; Alexander Marks; Martin Bergmann; Klaus Steger
Journal:  Anat Embryol (Berl)       Date:  2004-11-19

4.  Immunohistochemical study of testicular sex cord-stromal tumors, including staining with anti-inhibin antibody.

Authors:  W G McCluggage; J H Shanks; C Whiteside; P Maxwell; S S Banerjee; J D Biggart
Journal:  Am J Surg Pathol       Date:  1998-05       Impact factor: 6.394

5.  Frequency of so-called hypoplastic or dysgenetic zones in scrotal and otherwise normal human tests.

Authors:  C E Hedinger; R Huber; E Weber
Journal:  Virchows Arch Pathol Anat Physiol Klin Med       Date:  1967-03-14

6.  Sclerosing Sertoli cell tumor of the testis. A report of 10 cases.

Authors:  L R Zukerberg; R H Young; R E Scully
Journal:  Am J Surg Pathol       Date:  1991-09       Impact factor: 6.394

7.  Utility of immunohistochemistry in distinguishing ovarian sertoli-stromal cell tumors from carcinosarcomas.

Authors:  M J Costa; R J Morris; R Wilson; R Judd
Journal:  Hum Pathol       Date:  1992-07       Impact factor: 3.466

Review 8.  Large cell calcifying Sertoli cell tumor of the testis: contrasting features of six malignant and six benign tumors and a review of the literature.

Authors:  S S Kratzer; T M Ulbright; A Talerman; J R Srigley; L M Roth; G R Wahle; M Moussa; J K Stephens; A Millos; R H Young
Journal:  Am J Surg Pathol       Date:  1997-11       Impact factor: 6.394

9.  Sertoli cell tumors of the testis, not otherwise specified: a clinicopathologic analysis of 60 cases.

Authors:  R H Young; D D Koelliker; R E Scully
Journal:  Am J Surg Pathol       Date:  1998-06       Impact factor: 6.394

10.  The cancer-testis gene, NY-ESO-1, is expressed in normal fetal and adult testes and in spermatocytic seminomas and testicular carcinoma in situ.

Authors:  Anne-Pascale Satie; Ewa Rajpert-De Meyts; Giulio C Spagnoli; Sébastien Henno; Laurence Olivo; Grete Krag Jacobsen; Nathalie Rioux-Leclercq; Bernard Jégou; Michel Samson
Journal:  Lab Invest       Date:  2002-06       Impact factor: 5.662

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.